Mirati Therapeutics, Inc. | TalkMarkets

Latest Posts

Bristol-Myers To Buy Karuna Therapeutics For $14B

Article By: Zacks Investment Research

Friday, December 22, 2023 11:11 AM EDT

Bristol-Myers Squibb announced that it will acquire the biopharmaceutical company Karuna Therapeutics, Inc. for $330.00 per share in cash for a total equity value of $14 billion in a move to strengthen its neuroscience portfolio.

In this article: BMY, KRTX Also: MRTX, ABBV

Read

Whither Small Caps After Fed’s Tough Talk?

Article By: Rod Raynovich

Monday, August 29, 2022 4:16 AM EDT

For now its better not to “Fight the Fed” because they are fighting the with the market. Now that everyone is scared of the Fed's rhetoric it would be better to wait a week or so as more data and earnings reports become available.

In this article: IWM, XBI, CCXI Also: CYRX, QDEL, MRNA, EVH, MRTX, VCYT

Read

Biotech ETF Tops In June: 5 Stocks That Outperform

Article By: Sweta Killa

Thursday, June 30, 2022 2:48 PM EDT

Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%.

In this article: BBC, MRTX, KZR, DAWN, RPTX, LYEL

Read

Bear Market Rally Lifts HealthCare Stocks Off Bottom

Article By: Rod Raynovich

Wednesday, June 22, 2022 5:36 AM EDT

Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.

In this article: LLY, UNH, XLV, CRSP Also: CCXI, EVH, MRTX, MDGL, VCYT

Read

Stocks Pacing For Weekly Losses Despite Strong Jobs Data

Article By: Schaeffers Research

Friday, June 3, 2022 12:10 PM EDT

Wall Street is unpacking a strong jobs report this afternoon, though stocks are sliding as economists weigh the U.S. Federal Reserve's plans to continue hiking interest rates.

In this article: HCP, AMGN, NDX, SPX, DJI, MRTX, DBX

Read

All Posts